Abivax SA Statistics
NASDAQ: ABVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
73.20-7.45 (-9.24%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Abivax SA by the numbers
Abivax SA has a market capitalization of $6.41 billion based on 87.54M shares outstanding. With trailing EPS of $-6.08, Abivax SA is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.7% below its 50-day average and 34.5% below its 200-day average.
Average daily trading volume is 1.35M shares, or about $98.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABVX valuation vs. peer median
| Metric | ABVX | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.41B | $6.11B | +5% |
| Avg. volume | 1.35M | 1.06M | +27% |
Peer median across 8 companies: MIRM, AXSM, SUPN, CORT, ARWR, CYTK, LGND, GRFS.
Valuation
- Market cap
- $6.41B
- EPS (TTM)
- $-6.08
- Shares outstanding
- 87.54M
Price and trading
- Previous close
- 80.65
- Open
- 79.01
- Day range
- 62.97 – 79.74
- 52-week range
- 62.70 – 148.83
- 52-week change
- -38.55%
- 200-day moving average
- 111.78
- Beta
- —
- Volume
- 14.85M
- Average volume
- 1.35M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 21, 2026
Additional statistics
- Market Cap
- 6.41B
- Forward Pe
- -19.09
- Eps
- -6.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 148.83
- Week52 Low
- 62.70
- Avg Volume
- 1.35M
- Shares Outstanding
- 87.54M
- Ma50
- 91.16
- Ma200
- 111.78
- Earnings Date
- Dec 21, 2026
- Pct From52w High
- -50.82%
- Pct From52w Low
- 16.75%